Medical cannabis tax ‘hurting patients,’ advocate says
TORONTO – Cannabis industry players welcomed the change in the Federal Budget to tax edibles, extracts, oils and concentrates based on the amount of tetrahydrocannabinol rather than weight, as it could ease pricing for some products and potentially boost product availability.
However, licensed producers and a patient advocate group say they are disappointed that medical cannabis will continue to be taxed, despite a campaign calling on Ottawa to exempt patients.
Organigram’s chief executive officer Greg Engel said under the new framework, prices for some of these next-generation cannabis products, depending on potency of THC, could see some relaxation.
Sorry, the comment form is closed at this time.